Woodland, CAFounded 20226+ employeesPrivate
$16.5M raisedSeries A· last: series a (Mar 2025)· 3 rounds
Backed by(17 investors)
It takes 5 years for pharma to develop long lasting drug injections for chronic diseases like cancer and diabetes. Persist uses AI-driven automation to reduce formulation development time down to 2 years, a ~50% reduction.
